Table 4.
Correlations between the expression of lncRNA XIST, miR-129-5p and TNFSF10 and clinicopathological features in BC patients
| Clinicopathological Parameters | Case | lncRNA XIST | P value | Case | miR-129-5p | P value | Case | TNFSF10 | P value | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Low | High | Low | High | Low | High | |||||||
| Gender | 0.002 | 0.390 | 0.774 | |||||||||
| Male | 43 | 27 | 16 | 43 | 23 | 20 | 43 | 21 | 22 | |||
| Female | 17 | 3 | 14 | 17 | 7 | 10 | 17 | 9 | 8 | |||
| Age(years) | 0.100 | 0.273 | 0.584 | |||||||||
| ≤ 60 | 20 | 7 | 13 | 20 | 8 | 12 | 20 | 9 | 11 | |||
| > 60 | 40 | 23 | 17 | 40 | 22 | 18 | 40 | 21 | 19 | |||
| T stage | 0.404 | 0.931 | 0.471 | |||||||||
| Ta | 24 | 14 | 10 | 24 | 14 | 10 | 24 | 9 | 15 | |||
| T1 | 6 | 4 | 2 | 6 | 3 | 3 | 6 | 3 | 3 | |||
| T2 | 17 | 8 | 9 | 17 | 8 | 9 | 17 | 9 | 8 | |||
| T3 | 6 | 2 | 4 | 6 | 3 | 3 | 6 | 3 | 2 | |||
| T4 | 5 | 1 | 4 | 5 | 2 | 3 | 5 | 4 | 1 | |||
| Grade | 0.115 | 0.039 | ||||||||||
| Low | 13 | 9 | 4 | 13 | 10 | 3 | 13 | 6 | 7 | 0.753 | ||
| High | 45 | 20 | 25 | 45 | 20 | 25 | 45 | 23 | 22 | |||